Compare LEGN & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEGN | EAT |
|---|---|---|
| Founded | 2014 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 8.1B |
| IPO Year | 2020 | 1994 |
| Metric | LEGN | EAT |
|---|---|---|
| Price | $19.18 | $182.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 23 |
| Target Price | $45.62 | ★ $261.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.0M |
| Earning Date | 11-11-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.65 |
| EPS | N/A | ★ 10.87 |
| Revenue | N/A | ★ $5,807,400,000.00 |
| Revenue This Year | $39.73 | $8.23 |
| Revenue Next Year | $23.42 | $3.00 |
| P/E Ratio | ★ N/A | $17.45 |
| Revenue Growth | N/A | ★ 7.86 |
| 52 Week Low | $16.24 | $100.30 |
| 52 Week High | $37.50 | $254.99 |
| Indicator | LEGN | EAT |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 35.48 |
| Support Level | $17.08 | $130.47 |
| Resistance Level | $19.92 | $212.23 |
| Average True Range (ATR) | 0.86 | 8.14 |
| MACD | 0.11 | -0.47 |
| Stochastic Oscillator | 68.43 | 0.58 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Brinker International is a leading casual dining operator and franchisor. Chili's, its largest banner and the second-largest casual dining concept in the US, is known for its American/Southwest-inspired menu. In fiscal 2026, the segment generated $5.3 billion in revenue (92% of consolidated sales) across 1,114 company-owned restaurants in the US and 469 franchised locations (the bulk of which are in international markets). The Italian casual-dining concept Maggiano's accounts for the remainder of the business, with 52 domestic units.